Industry: In the next 5 to 10 years, the level of China's medical equipment may be equal to that of Europe

Looking back at the past 10 years of the medical equipment industry: In the five years since the 2010 version of GMP was implemented, China’s medical equipment has accelerated the upgrading and the market scale has continued to expand.
After the end of the new version of GMP certification, consistency evaluation, centralized procurement and other medical reform policies Promoting and forcing the pharmaceutical industry to upgrade has also brought a new round of opportunities to the pharmaceutical equipment industry
.
Therefore, the past 10 years can be said to be the 10 years of rapid development of the industry
.
After years of development, China has now become a big country in medical equipment.
The equipment on the market has a wide range of equipment and complete specifications, which can basically meet the needs of the market.
Some of the technical levels have reached or even exceeded foreign products
.
However, due to a late start and weak technical experience, the overall level of domestic medical equipment still has a large gap compared with medical equipment in Europe, America, Japan and other countries
.
From the perspective of the industry, 10 years ago, the gap between China's medical equipment and Europe was more than 30 years, and it is expected that in 5-10 years, China's medical equipment will be evenly matched with Europe
.
Medical equipment (picture source: Pharmaceutical Network) From the perspective of the gap, compared with European equipment, domestic equipment is mainly reflected in three aspects: original technology, product quality and brand effect
.
The industry believes that these are also the directions that domestic medical equipment companies need to make efforts in the next 10 years
.
First, the lack of original technology for domestic medical equipment, the long-term dependence on imports for some core technologies and parts, the situation of being restricted by people, and the difficulty in occupying a stable market share
.
This is mainly because domestic enterprises are mainly small and medium-sized enterprises, and it is difficult to invest large sums of money in research and development, which makes the overall innovation level of the industry not high
.
In addition, in the past, China's medical equipment industry lacked some reasonable and stable incentive policies for the research and development of domestic equipment.
Researchers lacked interest or tasted the independent research and development of domestic equipment, which made the overall research and development foundation of domestic medical equipment weak
.
Second, the quality of domestic medical equipment products is not high, and the performance is not stable enough.
Most of them are low-level and repetitive production, and they lack the "right to speak" in the market, especially in the high-end market
.
Purchasers of pharmaceutical companies with sufficient funds tend to purchase higher-quality and higher-level imported equipment
.
Third, the brand effect of domestic medical equipment is not enough
.
As the standards and specifications for domestically-made medical equipment are not yet complete, some pharmaceutical machinery companies can only explore and build equipment on their own.
In the absence of specific parameters, the brand strength of domestically-made medical equipment is far less than that of some international brands
.
So, how to solve the above three bottlenecks? The industry believes that it is fundamentally necessary to solve the human problem and establish a workforce that matches the advanced production methods
.
Pharmaceutical equipment is a complex and comprehensive application subject, involving many fields such as pharmacy
.
In order to consolidate the foundation of research and development and improve the level of original technology, it is necessary to cultivate and train a group of high-quality and practical experience talents who have a solid foundation, are based on the frontiers of science, and master the knowledge of the field involved
.
At the same time, the company must also run in with the R&D team and work hard to learn the spirit of "craftsman" in order to develop original domestic medical equipment with independent intellectual property rights
.
In addition, relevant and continuous incentive policies are also needed to encourage and support domestic pharmaceutical equipment companies to in-depth research and develop original products
.
It is understood that due to insufficient funds, many companies just produce, improve and sell instruments that are popular in the market, and gain users' favor by improving digitization and automation, adding some functions, and improving appearance designs
.
How can this kind of minor revisions compare with the original level? In recent years, it can be seen that pharmaceutical machinery companies represented by Chutian Technology and Tofflon have seized market opportunities and increased R&D investment year by year, while paying more attention to personnel training and team building, and striving to improve the innovation level of domestic pharmaceutical equipment.

.
In addition, the standards of the pharmaceutical equipment industry are constantly being improved, and policies to encourage and support the development of high-end pharmaceutical equipment are also being continuously introduced
.
In this regard, the author believes that domestic medical equipment companies should build up confidence, make up for the three shortcomings, first catch up with themselves, and then compete with imported equipment, speed up the process of domestic substitution of imported equipment, and help domestic medical equipment to reach a new level.

.